SM-27   Click here for help

GtoPdb Ligand ID: 14598

Compound class: Synthetic organic
Comment: SM-27 is a small molecule-drug conjugate (SMDC) [2]. It is made up of a ligand that targets aldo-keto reductase family 1 member C3 (AKR1C3) inside tumour cells, with a cathepsin B-cleavable linkage to the cytotoxic agent gemcitabine. The linker contains a valine-alanine dipeptide bridge that is specifically recognized and cleaved by cathepsin B (CTSB; which is highly expressed by tumour cells) [1,3]. SM-27 is intended to selectively deliver the chemotherapeutic to tumour cells, whilst reducing off-target or bystander toxicity.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 16
Hydrogen bond donors 6
Rotatable bonds 19
Topological polar surface area 238.81
Molecular weight 811.79
XLogP 0.99
No. Lipinski's rules broken 4

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)[C@@H](C(=O)N[C@@H](C)C(=O)NC1=NC(=O)N(C=C1)[C@H]2C([C@@H]([C@@H](CO)O2)O)(F)F)NC(=O)C3=CC(=CC(=C3)NC(=O)C4=C(C=CC=C4)OCC5=C(C)ON=C5C)OC
Isomeric SMILES CC([C@@H](C(N[C@H](C(NC=1C=CN(C(N1)=O)[C@@H]2O[C@@H]([C@H](C2(F)F)O)CO)=O)C)=O)NC(C3=CC(NC(C4=CC=CC=C4OCC5=C(ON=C5C)C)=O)=CC(OC)=C3)=O)C
InChI InChI=1S/C38H43F2N7O11/c1-18(2)30(35(53)41-20(4)32(50)43-29-11-12-47(37(54)44-29)36-38(39,40)31(49)28(16-48)57-36)45-33(51)22-13-23(15-24(14-22)55-6)42-34(52)25-9-7-8-10-27(25)56-17-26-19(3)46-58-21(26)5/h7-15,18,20,28,30-31,36,48-49H,16-17H2,1-6H3,(H,41,53)(H,42,52)(H,45,51)(H,43,44,50,54)/t20-,28+,30-,31+,36+/m0/s1
InChI Key MTEGMVHIFRAMCD-PGVMJHPASA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
AKR1C3 and cathepsin B must both be present in the cells to trigger the antitumour activity of SM-27 [2]. SM-27 is active against xenograph tumours in vivo.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
AKR1C3 Hs Inhibitor Inhibition 8.1 pIC50 - 2
⤷ pIC50 8.1 (IC50 9x10-9 M) [2]